# Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery

Source: https://onco.cc/trials/nct00542542/  
OnCo record `nct00542542` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Fentanyl in Breast cancer, run by M.D. Anderson Cancer Center, completed.

## Summary

Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery is a phase 3 interventional study registered as NCT00542542 by M.D. Anderson Cancer Center, with 89 participants recorded, started 2007-09 and reaching its primary completion in 2014-03. Interventions recorded: Paravertebral Block, Propofol, Fentanyl, Ropivacaine, Midazolam. Conditions recorded: Breast Cancer.

Linked to the drug Fentanyl because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: completed
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT00542542
- Phase: 3
- Setting: Prospective Randomized Clinical Trial to Evaluate the Use of Paravertebral Blocks in Reconstructive Breast Surgery
- Sponsor: M.D. Anderson Cancer Center
- Enrolled: 89

## Sources

- ClinicalTrials.gov NCT00542542: https://clinicaltrials.gov/study/NCT00542542

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- drugs: [Fentanyl (transmucosal, for breakthrough cancer pain)](https://onco.cc/drugs/fentanyl/)

---
JSON: https://onco.cc/api/v1/entities/nct00542542.json